DelistingJun 4, 2026, 04:06 PM
Zhengye Biotechnology receives Nasdaq minimum bid price non-compliance notice
AI Summary
Zhengye Biotechnology Holding Limited announced it received a written notification from Nasdaq on May 29, 2026, indicating non-compliance with the minimum bid price requirement of US$1.00 per share. The company's Class A ordinary shares traded below this threshold for 30 consecutive business days. Zhengye Biotechnology has 180 calendar days, until November 25, 2026, to regain compliance by maintaining a closing bid price of at least US$1.00 for a minimum of 10 consecutive business days. The company is monitoring the situation and may consider options such as a reverse share split, though its business operations are not currently impacted.
Key Highlights
- Received Nasdaq non-compliance notification on May 29, 2026.
- Failed to meet Nasdaq's US$1.00 minimum bid price requirement.
- Deficiency observed for 30 consecutive business days from April 16 to May 28, 2026.
- Has 180 calendar days, until November 25, 2026, to regain compliance.
- Must achieve a closing bid price of at least US$1.00 for 10 consecutive business days.
- Company may consider a reverse share split to regain compliance.
- Business operations are currently unaffected by the notification.
Price Impact
More from ZYBT